Skip to main content

2020 | Klimakterium und Menopause | OriginalPaper | Buchkapitel

27. Peri- und Postmenopause – Diagnostik und Therapie

verfasst von : Olaf Ortmann

Erschienen in: Therapiehandbuch Gynäkologie und Geburtshilfe

Verlag: Springer Berlin Heidelberg

Zusammenfassung

Frauen erleben in ihrer Lebensmitte eine Übergangsphase zwischen regelmäßiger zyklischer Ovarialfunktion und deren Sistieren. Die damit verbundenen Veränderungen der Steroidhormonsynthese sind physiologisch. Sie können mit einer Reihe von Symptomen verbunden sein, die die Lebensqualität der Frauen z. T. relevant beeinträchtigen.
Literatur
Zurück zum Zitat Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, Bonds D, Brunner RL, Brzyski RG, Caan BJ (2004) Effects of conjugated equine estrogen in postmenopausal women with a hysterectomy. JAMA 291:1701–1712 CrossRef Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, Bonds D, Brunner RL, Brzyski RG, Caan BJ (2004) Effects of conjugated equine estrogen in postmenopausal women with a hysterectomy. JAMA 291:1701–1712 CrossRef
Zurück zum Zitat Avis NE, Crawford SL, Greendale G, Bromberger JT, Everson-Rose SA, Gold EB, Hess R, Joffe H, Kravitz HM, Tepper PG, Thurston RC (2015) Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Intern Med 175(4):531–539 Avis NE, Crawford SL, Greendale G, Bromberger JT, Everson-Rose SA, Gold EB, Hess R, Joffe H, Kravitz HM, Tepper PG, Thurston RC (2015) Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Intern Med 175(4):531–539
Zurück zum Zitat Avis NE, Colvin A, Bromberger JT, Hess R, Matthews KA, Ory M, Schocken M (2009) Change in health-related quality of life over the menopausal transisiton in an multiethnic cohort of middle-aged women: Study of Womens’s Health Across the Nation (SWAN). Neurology 72(21):1850–1857 CrossRef Avis NE, Colvin A, Bromberger JT, Hess R, Matthews KA, Ory M, Schocken M (2009) Change in health-related quality of life over the menopausal transisiton in an multiethnic cohort of middle-aged women: Study of Womens’s Health Across the Nation (SWAN). Neurology 72(21):1850–1857 CrossRef
Zurück zum Zitat Beral V, Million Women, Study Collaborators (2003) Breast cancer and hormone-replacement therapy in the million women study. Lancet 362:419–427 (Erratum appears in Lancet 2003 Oct 4; 362(9390):1160) CrossRef Beral V, Million Women, Study Collaborators (2003) Breast cancer and hormone-replacement therapy in the million women study. Lancet 362:419–427 (Erratum appears in Lancet 2003 Oct 4; 362(9390):1160) CrossRef
Zurück zum Zitat Beral V, Bull D, Reeves G, Million Women Study Collaborators (2005) Endometrial cancer and hormone-replacement therapy in the Million Women Study. Lancet 365(9470):1543–1551 CrossRef Beral V, Bull D, Reeves G, Million Women Study Collaborators (2005) Endometrial cancer and hormone-replacement therapy in the Million Women Study. Lancet 365(9470):1543–1551 CrossRef
Zurück zum Zitat Collaborative Group on Epidemiological Studies of Ovarian Cancer (2015) Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies. Lancet 385:1835–1842 CrossRef Collaborative Group on Epidemiological Studies of Ovarian Cancer (2015) Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies. Lancet 385:1835–1842 CrossRef
Zurück zum Zitat Gordon JL, Rubinow DR, Eisenlohr-Moul TA, Xia K, Schmidt PJ, Girdler SS (2018) Efficacy of transdermal estradiol and micronized progesterone in the prevention of depressive symptoms in the menopause transition: A randomized clinical trial. JAMA Psychiatry 75(2):149–157 CrossRef Gordon JL, Rubinow DR, Eisenlohr-Moul TA, Xia K, Schmidt PJ, Girdler SS (2018) Efficacy of transdermal estradiol and micronized progesterone in the prevention of depressive symptoms in the menopause transition: A randomized clinical trial. JAMA Psychiatry 75(2):149–157 CrossRef
Zurück zum Zitat Harlow SD, Goss M, Hall JE et al. (2012) Executive summary of the Stages of Reproductive Aging Workshop + 10: Addressing the unfinished agenda of staging reproductive aging. J Clin Endocrinol Metab 97:1159–1168 Harlow SD, Goss M, Hall JE et al. (2012) Executive summary of the Stages of Reproductive Aging Workshop + 10: Addressing the unfinished agenda of staging reproductive aging. J Clin Endocrinol Metab 97:1159–1168
Zurück zum Zitat Lattrich C, Hadji P, Ortmann O (2014) Perimenopause Postmenopause und Senium. In: Leidenberger FA, Strowitzki T, Ortmann O (Hrsg) Klinische Endokrinologie für Frauenärzte, 2. Aufl. Springer, Heidelberg Lattrich C, Hadji P, Ortmann O (2014) Perimenopause Postmenopause und Senium. In: Leidenberger FA, Strowitzki T, Ortmann O (Hrsg) Klinische Endokrinologie für Frauenärzte, 2. Aufl. Springer, Heidelberg
Zurück zum Zitat Lin KJ, Cheung WY, Lai JY et al (2012) The effect of estrogen vs. combined estrogen-progestin therapy on the risk of colorectal cancer. Int J Cancer 130:419–430 CrossRef Lin KJ, Cheung WY, Lai JY et al (2012) The effect of estrogen vs. combined estrogen-progestin therapy on the risk of colorectal cancer. Int J Cancer 130:419–430 CrossRef
Zurück zum Zitat Maki PM, Kornstein SG, Joffe H, Bromberger JT, Freeman EW, Athappilly G, Bobo WV, Rubin LH, Koleva HK, Cohen LS, Soares CN (2018) Board of trustees for The North American Menopause Society (NAMS) and the women and mood disorders task force of the national network of depression centers. Menopause 25(10):1069–1085 CrossRef Maki PM, Kornstein SG, Joffe H, Bromberger JT, Freeman EW, Athappilly G, Bobo WV, Rubin LH, Koleva HK, Cohen LS, Soares CN (2018) Board of trustees for The North American Menopause Society (NAMS) and the women and mood disorders task force of the national network of depression centers. Menopause 25(10):1069–1085 CrossRef
Zurück zum Zitat Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR, Lasser NL, Trevisan M, Black HR, Heckbert SR, Detrano R, Strickland OL, Wong ND, Crouse JR, Stein E, Cushman M, Women’s Health Initiative Investigators (2003) Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 349:523–534 CrossRef Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR, Lasser NL, Trevisan M, Black HR, Heckbert SR, Detrano R, Strickland OL, Wong ND, Crouse JR, Stein E, Cushman M, Women’s Health Initiative Investigators (2003) Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 349:523–534 CrossRef
Zurück zum Zitat Manson JE, Chlebowski RT, Stefanick ML, Aragaki AK, Rossouw JE, Prentice RL, Anderson G, Howard BV, Thomson CA, LaCroix AZ, Wactawski-Wende J, Jackson RD, Limacher M, Margolis KL, Wassertheil-Smoller S, Beresford SA, Cauley JA, Eaton CB, Gass M, Hsia J, Johnson KC, Kooperberg C, Kuller LH, Lewis CE, Liu S, Martin LW, Ockene JK, O’Sullivan MJ, Powell LH, Simon MS, Van Horn L, Vitolins MZ, Wallace RB (2013) Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the women’s health Initiative randomized trials. JAMA 310:1353–1368 CrossRef Manson JE, Chlebowski RT, Stefanick ML, Aragaki AK, Rossouw JE, Prentice RL, Anderson G, Howard BV, Thomson CA, LaCroix AZ, Wactawski-Wende J, Jackson RD, Limacher M, Margolis KL, Wassertheil-Smoller S, Beresford SA, Cauley JA, Eaton CB, Gass M, Hsia J, Johnson KC, Kooperberg C, Kuller LH, Lewis CE, Liu S, Martin LW, Ockene JK, O’Sullivan MJ, Powell LH, Simon MS, Van Horn L, Vitolins MZ, Wallace RB (2013) Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the women’s health Initiative randomized trials. JAMA 310:1353–1368 CrossRef
Zurück zum Zitat Manson JE, Aragaki AK, Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Chlebowski RT, Howard BV, Thomson CA, Margolis KL, Lewis CE, Stefanick ML, Jackson RD, Johnson KC, Martin LW, Shumaker SA, Espeland MA, Wactawski-Wende J, WHI Investigators (2017) Menopausal hormone therapy and long-term all-cause and cause-specific mortality: the women’s health initiative randomized trials. JAMA 318(10):927–938 CrossRef Manson JE, Aragaki AK, Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Chlebowski RT, Howard BV, Thomson CA, Margolis KL, Lewis CE, Stefanick ML, Jackson RD, Johnson KC, Martin LW, Shumaker SA, Espeland MA, Wactawski-Wende J, WHI Investigators (2017) Menopausal hormone therapy and long-term all-cause and cause-specific mortality: the women’s health initiative randomized trials. JAMA 318(10):927–938 CrossRef
Zurück zum Zitat Manson JE, Kaunitz AM (2016) Menopause management-getting clinical care back on track. N Engl J Med 374:803–806 CrossRef Manson JE, Kaunitz AM (2016) Menopause management-getting clinical care back on track. N Engl J Med 374:803–806 CrossRef
Zurück zum Zitat Nelson HD, Haney E, Humphrey L, Miller J, Nedrow A, Nicolaidis C, Vesco K, Walker M, Bougatsos C, Nygren P (2005) Management of Menopause-Related Symptoms. Evid Rep Technol Assess 120:12 Nelson HD, Haney E, Humphrey L, Miller J, Nedrow A, Nicolaidis C, Vesco K, Walker M, Bougatsos C, Nygren P (2005) Management of Menopause-Related Symptoms. Evid Rep Technol Assess 120:12
Zurück zum Zitat Prophylaxe, Diagnostik und Therapie der OSTEOPOROSE bei Männern ab dem 60. Lebensjahr und bei postmenopausalen Frauen, Leitlinie des Dachverbands der Deutschsprachigen Wissenschaftlichen Osteologischen Gesellschaften e. V., 2017 Prophylaxe, Diagnostik und Therapie der OSTEOPOROSE bei Männern ab dem 60. Lebensjahr und bei postmenopausalen Frauen, Leitlinie des Dachverbands der Deutschsprachigen Wissenschaftlichen Osteologischen Gesellschaften e. V., 2017
Zurück zum Zitat Shim SH, Lee SJ, Kim SN (2014) Effects of hormone replacement therapy on the rate of recurrence in endometrial cancer survivors: a meta-analysis. Eur J Cancer 50(9):1628–1637 CrossRef Shim SH, Lee SJ, Kim SN (2014) Effects of hormone replacement therapy on the rate of recurrence in endometrial cancer survivors: a meta-analysis. Eur J Cancer 50(9):1628–1637 CrossRef
Metadaten
Titel
Peri- und Postmenopause – Diagnostik und Therapie
verfasst von
Olaf Ortmann
Copyright-Jahr
2020
Verlag
Springer Berlin Heidelberg
DOI
https://doi.org/10.1007/978-3-662-59809-2_27

Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Gynäkologie und bleiben Sie gut informiert – ganz bequem per eMail.